The Lancet｜Long COVID: a clinical update

2024-11-04

Nature｜The global H5N1 influenza panzootic in mammals

2024-10-08

Nature｜Five ways science is tackling the antibiotic resistance crisis

2024-09-12

The Lancet｜Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials

2024-08-30

Nature Human Behaviour｜A systematic review and meta-analysis of strategies to promote vaccination uptake

2024-08-12

Lancet Diabetes Endocrinol | Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people

Background Some studies have shown that the incidence of type 2 diabetes increases after a diagnosis of COVID-19, although the evidence is not conclusive. However, the effects of the COVID-19 vaccine on this association, or the effect on other diabetes subtypes, are not clear. We aimed to investigate the association between COVID-19 and incidence of type 2, type 1, gestational and non-specific diabetes, and the effect of COVID- 19 vaccination, up to 52 weeks after diagnosis.

2024-08-01

Lencet Diabetes Endocrinol | Associations between BMI and hospital resource use in patients hospitalised for COVID-19 in England: a community-based cohort study

Associations between BMI and hospital resource use in patients hospitalised for COVID-19 in England: a community-based cohort study

2024-07-22

Science | Future malaria environmental suitability in Africa is sensitive to hydrology

Anthropogenic change is contributing to the rise in emerging infectious diseases, which are significantly correlated with socioeconomic, environmental and ecological factors1. Studies have shown that infectious disease risk is modified by changes to biodiversity2-6, climate change7-11, chemical pollution12-14, landscape transformations15-20 and species introductions21. However, it remains unclear which global change drivers most increase disease and under what contexts. Here

2024-05-10